SPAC Overview
$173M
IPO Size
$157M
Trust (as of 2026-06-30)
Definitive Agreement
Current Status
2024
IPO Year
Timeline Progress
About
Translational Development Acquisition Corp. is a newly organized blank-check company seeking to complete an initial business combination with one or more businesses. It has not identified a target and states that it may pursue an opportunity in any business, industry, sector, or geographic location.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
North American, European
The terms and the filing trail behind Translational Development Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Michael B. Hoffman
Chairman of the Board of Directors, Chief Executive Officer, Director
Avanindra Das
Chief Financial Officer
Christopher Kenneth Jarratt
Director Nominee
Curtis T. Keith
Director Nominee
e Premkumar Reddy
Director Nominee
John M. Glazer
Director Nominee
Maria L. Maccecchini
Director Nominee
Matthew Adam Kestenbaum
Director Nominee
Susan P. Kennedy
Director Nominee
Paul A. Brooke
Beneficial owner
Prem Reddy
Beneficial owner
Underwriters
Extended Team Information
The management team has experience in energy investment, finance, renewable energy, infrastructure, mergers and acquisitions, biotechnology, and prior SPACs.
Stock Performance
TDACU
Trading Symbol
First Trade
December 23, 2024
$10.01
Current Price
October 1, 2026
$12.11
+21%
Key Information
IPO Date
December 23, 2024
Total Redemptions
$27.8M
SIC
6770
Merger Target
Prologium Holding Inc.
SPAC Ticker
TDAC